XML 27 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2017
Summary of Significant Accounting Policies [Abstract]  
Schedule of Estimated Future Amortization Expense



 

 

 

 



 

 

 

 

Fiscal Years ending December 31,

 

 

 

Total Amortization



 

 

 

(unaudited)

2017 (nine months remaining)

 

 

$

40 

2018

 

 

 

54 

2019

 

 

 

32 

2020

 

 

 

2021

 

 

 

Later years

 

 

 

32 



 

 

$

175 



Summary of Activity Related to Warranty Liability Included in Other Current Liabilities



 

 

 

 

 

 

 

 



 

Three Months Ended 

 



 

March 31,

 



 

2017

 

 

2016

 



 

 

(unaudited)

 

Beginning balance

 

$

584 

 

 

$

599 

 

Warranty accruals

 

 

116 

 

 

 

 

Warranty claims

 

 

(91)

 

 

 

(46)

 

Ending balance

 

$

609 

 

 

$

555 

 



Schedule of Earnings Per Share, Basic and Diluted



 

 

 

 

 

 



Three Months Ended

 



March 31

 



(unaudited)

 



2017

 

 

2016

 



 

 

 

 

 

 

Net (loss) income

$

(1,999)

 

$

14 

 

Income allocated to participating securities

 

 —

 

 

 

(Loss) income allocated to common shares

$

(1,999)

 

$

11 

 



 

 

 

 

 

 



 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

31,628,997 

 

 

29,388,104 

 

Dilutive effect of stock options

 

 —

 

 

249,700 

 

Weighted average common shares outstanding - Diluted

 

31,628,997 

 

 

29,637,804 

 



 

 

 

 

 

 

Net (loss) income per share:

 

 

 

 

 

 

    Basic

$

(0.06)

 

$

 -

 

    Diluted

$

(0.06)

 

$

 -

 



 

 

 

 

 

 



Schedule of Potentially Dilutive Common Stock Equivalents



 

 

 

 

 



 

 

 

 

 



 

For the Three Months  Ended March 31,

 



 

2017

 

2016

 



 

(unaudited)

 

Options

 

5,044,631 

 

4,238,502 

 

Warrants

 

3,431,449 

 

2,600,000 

 

Convertible preferred stock

 

7,545,333 

 

7,545,333 

 

Total potentially dilutive common stock equivalents

 

16,021,413 

 

14,383,835